Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanespimycin plus Bortezomib in Relapsed Multiple Myeloma
NCT00546780Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tanespimycin in multiple myeloma (MM), sponsored by Bristol Myers Squibb. Started Feb 2008; status: completed.
02
Drugs
tanespimycin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00546780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546780.